XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Beginning balance (in shares) at Dec. 31, 2021 34,980,896        
Beginning balance at Dec. 31, 2021 $ 35 $ 367,907 $ (288,702)   $ 79,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   168     168
Exercise of stock options (in shares) 35,453        
Issuance of common stock upon vesting of restricted stock units (in shares) 57,253        
Stock-based compensation   4,978     4,978
Net loss     (16,679)   (16,679)
Ending balance (in shares) at Mar. 31, 2022 35,073,602        
Ending balance at Mar. 31, 2022 $ 35 373,053 (305,381)   67,707
Beginning balance (in shares) at Dec. 31, 2022 38,355,972        
Beginning balance at Dec. 31, 2022 $ 38 507,715 (343,712) $ (166) 163,875
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   1,110     $ 1,110
Exercise of stock options (in shares) 144,474       144,474
Issuance of common stock upon vesting of restricted stock units $ 1       $ 1
Issuance of common stock upon vesting of restricted stock units (in shares) 207,995        
Stock-based compensation   8,838     8,838
Net loss     (16,460)   (16,460)
Unrealized gain on investments, net       249 249
Ending balance (in shares) at Mar. 31, 2023 38,708,441        
Ending balance at Mar. 31, 2023 $ 39 $ 517,663 $ (360,172) $ 83 $ 157,613